Article Versions Notes

De Corso E, Settimi S, Penazzi D, D’Agostino G, Corbò M, Rigante M, Montuori C, Rizzuti A, Pacilli MC, Di Cesare T, et al. Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis. Journal of Personalized Medicine. 2024; 14(7):735. https://doi.org/10.3390/jpm14070735

De Corso, Eugenio, Stefano Settimi, Daniele Penazzi, Giuseppe D’Agostino, Marco Corbò, Mario Rigante, Claudio Montuori, Alberta Rizzuti, Maria Clara Pacilli, Tiziana Di Cesare, and et al. 2024. "Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis" Journal of Personalized Medicine 14, no. 7: 735. https://doi.org/10.3390/jpm14070735

De Corso, E., Settimi, S., Penazzi, D., D’Agostino, G., Corbò, M., Rigante, M., Montuori, C., Rizzuti, A., Pacilli, M. C., Di Cesare, T., Lo Verde, S., Rizzi, A., Chini, R., & Galli, J. (2024). Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis. Journal of Personalized Medicine, 14(7), 735. https://doi.org/10.3390/jpm14070735